O'Shaughnessy Asset Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

O'Shaughnessy Asset Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-69	Closed	-$3.73K	–	2846
2026 Q1	$3.73K	Buy	69 +4	+6%	+$223	﹤0.01%	2524
2025 Q4	$3.64K	Hold	65	–	–	﹤0.01%	2504
2025 Q3	$3.12K	Buy	+65	New	+$2.91K	﹤0.01%	2444

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

O'Shaughnessy Asset Management's XPH Position: Q2 2026 in Review

O'Shaughnessy Asset Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q2 2026, closing a stake of 69 shares — an estimated $3.73K sold.

O'Shaughnessy Asset Management first reported a position in XPH in Q3 2025 and held it in 3 quarters. The position peaked at $3.73K in Q1 2026. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

O'Shaughnessy Asset Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
O'Shaughnessy Asset Management sold 69 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $3.73K.
O'Shaughnessy Asset Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2025 and held it in 3 quarters.
O'Shaughnessy Asset Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $3.73K in Q1 2026.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.